U.S. Senator Tammy Baldwin Announces She Will Not Support Congressman Tom Price’s Confirmation for Secretary of Health and Human Services
"Congressman Price’s nomination process has revealed financial dealings that raise serious questions about potential STOCK Act violations."
WASHINGTON, D.C. – U.S. Senator Tammy Baldwin, a member of the Senate Health, Education, Labor and Pensions (HELP) Committee, today released the following statement announcing she will oppose Congressman Tom Price’s confirmation as Secretary of the Department of Health and Human Services (HHS):
“President Trump’s nominee, Congressman Tom Price, has a long record of spearheading legislation that would end Medicare as we know it and increase costs for seniors. This nominee has supported plans to cut state funding for Medicaid, which our states depend on to provide health care coverage for low-income children and families, and home and community care for seniors and the disabled. He has also led the charge, with many other politicians, to stand between women and their doctors by restricting women’s reproductive health care choices and denying them access to essential health services. This record is deeply troubling.
“I had a chance to meet with President Trump’s nominee and to question him at a hearing of the Senate Health, Education, Labor and Pensions Committee. Congressman Price refused to make a commitment to work on keeping the President’s promise to allow Medicare to negotiate lower prescription drugs prices for seniors. I have long supported allowing Medicare to negotiate better prices for prescription drugs and have cosponsored legislation to make this a reality, but Congressman Price declined to give me his word that the Trump Administration would keep the President’s promise and take action on this important reform to help lower out-of-pocket costs for seniors.
“Finally, Congressman Price’s nomination process has revealed financial dealings that raise serious questions about potential STOCK Act violations, illegal insider trading and other conflicts of interest. That is why I have called on the U.S. Securities and Exchange Commission (SEC) to investigate the stock market trading activities of Congressman Price.
“For all these reasons, I cannot and will not support Congressman Price’s confirmation for Secretary of Health and Human Services.”
Press Releases by Tammy Baldwin
Senators Call for Independent Prosecutor to Investigate Trump Officials’ Collusion with Russia and Apparent White House Cover-UpFeb 15th, 2017 by Tammy Baldwin
Senators to Sessions: “At stake is the integrity and honesty of our most trusted public officials and the viability of our justice system”
U.S. Senators Tammy Baldwin and Thom Tillis Introduce Bipartisan Legislation to Support Job Creation for America’s VeteransFeb 14th, 2017 by Tammy Baldwin
The BRAVE Act creates incentives for businesses to employ our veterans
"Dr. Shulkin has the experience and qualifications to provide the leadership necessary to get the job done..."
U.S. Senator Tammy Baldwin Urges New FCC Chair to Reverse Decision Threatening Low-Income Americans’ Broadband AccessFeb 10th, 2017 by Tammy Baldwin
Chairman Pai recently revoked the recognition of nine companies as providers for a critical program that has helped tens of millions of low-income Americans afford broadband service.
Baldwin, Warren Seek Information On Goldman Sachs’ Role In and Influence over Trump Administration Economic PoliciesFeb 10th, 2017 by Tammy Baldwin
Company stock up dramatically as former Goldman executive Gary Cohn and other Goldman bankers joined Trump Administration
U.S. Senator Tammy Baldwin Demands Answers About Outrageous Price Hike For Lifesaving Anti-Overdose DrugFeb 8th, 2017 by Tammy Baldwin
"...this startling price hike is very concerning."